Louis Lehot Legal Podcasts · 2024-06-10 · 1 min
According to a recent PitchBook report, medtech M&A is on the rise, especially with cardiovascular tech and surgical robotics.Key points to note about this recent shift:▪️ Q1 2024 saw $3.3B in funding, up from $2.8B in Q4 2023▪️ Cardiovascular and surgical robotics led the charge with $2.2B and $1B, respectively, in the past year▪️ About 1/2 of the Q1 funding went to later-stage deals.This surge in deal value suggests there could be a strong rest of the year ahead for manda activity. Stabilizing public medtech valuations could further contribute to this trend, allowing for new opportunities for growth and innovation.Give this Axios article a read for more. Discover more about Louis Lehot and explore additional professional insights on his website: Explore Related Content: This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit louislehotattorney.substack.com
DExit- Why Some Companies Are Leaving Delaware72 / 100
Louis Lehot Talks AI, Machine Learning, and Generative Technology65 / 100
How Managers Can Use AI to Boost Productivity 
The Venture Mindset | NACD
Harnessing Global Talent for AI development 